These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 39385110

  • 1. Donor age over 55 is associated with worse outcome in lung transplant recipients with idiopathic pulmonary fibrosis.
    Moneke I, Ogutur ED, Kornyeva A, Fähndrich S, Schibilsky D, Bierbaum S, Czerny M, Stolz D, Passlick B, Jungraithmayr W, Frye BC.
    BMC Pulm Med; 2024 Oct 09; 24(1):499. PubMed ID: 39385110
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.
    Warrior K, Sayad K, O'Hara CP, Dilling DF.
    Transplantation; 2024 Jun 01; 108(6):1460-1465. PubMed ID: 38291576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
    Fisher JH, Al-Hejaili F, Kandel S, Hirji A, Shapera S, Mura M.
    Respir Med; 2017 Apr 01; 125():65-71. PubMed ID: 28340864
    [Abstract] [Full Text] [Related]

  • 8. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Sims MW, Beers MF, Ahya VN, Kawut SM, Sims KD, Lederer DJ, Palmer SM, Wille K, Lama VN, Shah PD, Orens JB, Bhorade S, Crespo M, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB, Lung Transplant Outcomes Group.
    Chest; 2011 Aug 01; 140(2):489-496. PubMed ID: 21349925
    [Abstract] [Full Text] [Related]

  • 9. The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation.
    Rusanov V, Kramer MR, Raviv Y, Medalion B, Guber A, Shitrit D.
    Chest; 2012 Apr 01; 141(4):1047-1054. PubMed ID: 21940773
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.
    Clin Transpl; 2003 Apr 01; ():89-100. PubMed ID: 15387100
    [Abstract] [Full Text] [Related]

  • 14. Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis.
    Neurohr C, Huppmann P, Thum D, Leuschner W, von Wulffen W, Meis T, Leuchte H, Baumgartner R, Zimmermann G, Hatz R, Czerner S, Frey L, Ueberfuhr P, Bittmann I, Behr J, Munich Lung Transplant Group.
    Transpl Int; 2010 Sep 01; 23(9):887-96. PubMed ID: 20230541
    [Abstract] [Full Text] [Related]

  • 15. Single- and Double-Lung Transplantation: Results of an Initial Experience of 39 Cases in Ceará (Northeast Brazil).
    Gomes Neto A, Monteiro Nogueira AS, Lopes De Medeiros I, Fernandes Viana De Araujo R, Carvalho Santos R, Sampaio Viana CM, Moreira Batista Aguiar F, Gomes Catunda L, Araújo Aragão L, Fava Alencar R.
    Transplant Proc; 2018 Apr 01; 50(3):815-818. PubMed ID: 29661444
    [Abstract] [Full Text] [Related]

  • 16. [Extracorporeal membrane oxygenation as a bridge to lung transplantation].
    Xia W, Xu H, Mao W, Chen J.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec 01; 30(12):1167-1172. PubMed ID: 30592952
    [Abstract] [Full Text] [Related]

  • 17. Lung transplantation for high-risk patients with idiopathic pulmonary fibrosis.
    De Oliveira NC, Julliard W, Osaki S, Maloney JD, Cornwell RD, Sonetti DA, Meyer KC.
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct 07; 33(3):235-241. PubMed ID: 27758988
    [Abstract] [Full Text] [Related]

  • 18. Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
    Tuyls S, Verleden SE, Wuyts WA, Yserbyt J, Vos R, Verleden GM.
    Transpl Int; 2019 Apr 07; 32(4):399-409. PubMed ID: 30488486
    [Abstract] [Full Text] [Related]

  • 19. Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.
    Tanaka S, Miyoshi K, Higo H, Kurosaki T, Otani S, Sugimoto S, Yamane M, Kiura K, Toyooka S, Oto T.
    Respir Investig; 2019 Mar 07; 57(2):165-171. PubMed ID: 30600175
    [Abstract] [Full Text] [Related]

  • 20. A novel risk score that incorporates recipient and donor variables to predict 1-year mortality in the current era of lung transplantation.
    Grimm JC, Valero V, Magruder JT, Kilic A, Dungan SP, Silhan LL, Shah PD, Kim BS, Merlo CA, Sciortino CM, Shah AS.
    J Heart Lung Transplant; 2015 Nov 07; 34(11):1449-54. PubMed ID: 26275639
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.